Skip to main content

Avalyn Pharma Inc 10-Q for FY2026 Q3

Avalyn Pharma Inc. (AVLN)

10-Q 2026-11-12 For: 2026-09-30
View Original
Added on November 12, 2026

About this 10-Q

Avalyn Pharma Inc filed this 10-Q on November 12, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Avalyn Pharma reported a nine-month net loss of $85.5 million and $386.6 million in cash, cash equivalents and marketable securities as of September 30, 2026, which it expects to fund operations into 2029. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$29.66M
compared with a net loss of $23.58M a year earlier
Diluted EPS
-$0.67
compared with -$20.34 a year earlier